×
× Digital News Videos Health & Science Lifestyle Opinion Education Columnists Moi Cabinets Arts & Culture Ureport Fact Check The Standard Insider Kenya @ 50 Podcasts E-Paper Lifestyle & Entertainment Nairobian Entertainment Eve Woman Travelog TV Stations KTN Home KTN News BTV KTN Farmers TV Radio Stations Radio Maisha Spice FM Vybez Radio Enterprise VAS E-Learning Digger Classified Games Crosswords Sudoku The Standard Group Corporate Contact Us Rate Card Vacancies DCX O.M Portal Corporate Email RMS
×

Investment fund buys stake in Rwandan firm

By - | January 23rd 2013 at 00:00:00 GMT +0300

By John Oyuke

Kenyan-based venture capital fund, Fanisi Capital, has bought stake in a Rwandan pharmaceutical firm, Sophar Limited.

The investment in the Kigali-based company, which imports branded drugs, mostly from Europe and sells in Rwanda, represents a key milestone for the $50 million (Sh4.35 billion) equity fund as it is the first investment outside the country.

Though Fanisi did not disclose the amount invested, citing non-disclosure agreements with the drugs wholesaler, the fund usually make investments with initial values of between $1 and $3 million (approximately Sh87m and Sh261m).

Announcing the investment in Nairobi, the co-Managing Partner of Fanisi Capital, Ayisi Makatiani, said the funding, which was achieved through a mix of equity and debt, will be used to build a drugs warehouse in Kigali.

Read More

He said that the new investment would significantly expand the company product range from 900 to 3,000 products within a few years, and set up distribution centres for enhanced access and improve supply chain.

“A key benefit is that the investment will allow better access to drugs, especially for the neediest sections of the population,” stressed Makatiani.

 


 


investment fund firm pharmaceutical
Share this story

More stories


Feedback